Loading
A phase 2 trial of encorafenib, cetuximab and bevacizumab in colorectal cancer, run by Vall d'Hebron Institute of Oncology, now recruiting.
Combination Therapy for BRAF-V600E Metastatic CRCm is a phase 2, interventional study registered as NCT06411600 by Vall d'Hebron Institute of Oncology, with a registry enrolment figure of 94 participants, started 2024-05-17 and due to reach its primary completion in 2027-05-01. Interventions recorded: Encorafenib; Cetuximab; Bevacizumab. Conditions listed: Metastatic Colorectal Cancer. Primary outcome: Progression-Free Survival (PFS). Colorectal eligibility wording from the registry: "5 x ULN is allowed if direct (conjugated) ≤1". Sites: Spain. No results are recorded here; the registry entry is the source.
The full inclusion and exclusion criteria are on the registry record. Read 2026-10-07. Recruiting overall does not mean a particular site is open; ask the study team.
ClinicalTrials.gov data courtesy of the US National Library of Medicine.
Shares Cetuximab, Bevacizumab, Monoclonal antibodies, Colon cancer (adenocarcinoma of the colon) and the tag colorectal-deep-dive.
Shares Cetuximab, Monoclonal antibodies, Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.
Shares Cetuximab, Monoclonal antibodies, Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.
Shares Cetuximab, Monoclonal antibodies, Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.
Shares Cetuximab, Monoclonal antibodies, Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.
Shares Encorafenib, Cetuximab, Monoclonal antibodies, Colon cancer (adenocarcinoma of the colon) and the tag colorectal-deep-dive.
Shares Cetuximab, Bevacizumab, Monoclonal antibodies, Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.
Shares Encorafenib, Bevacizumab, Colorectal cancer trials open today (registry snapshot), Rectal cancer and the tag colorectal-deep-dive.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/